IMM International Metals Mining Corp

Immunotec Inc. (TSX VENTURE:IMM), a Canadian based company and a leader in the
wellness industry ("Immunotec" or the "Company"), today announced the
appointment of Mr. Charles L. Orr as its Chief Executive Officer. 


Mr. Orr has served since March 2009 as Executive Director of the Direct Selling
Education Foundation, where he held ultimate responsibility for the Foundation's
programs and activities. Since 2001, he has provided his proven and successful
expertise by active participation as a board member and advisor in a variety of
publicly traded and privately held organizations ranging from over a billion
dollars in revenue to start-ups. Mr. Orr served as President and Chief Executive
Officer of Shaklee Corporation (1993-2000), where he was responsible for the
performance of the company's diverse business units. Shaklee, then a $700m
revenue company, included the brand names of Harry and David, Jackson and
Perkins, and Shaklee. Mr. Orr has been a director of Immunotec since 2006.


Mr. Orr is a seasoned professional with 23 years of experience in the direct
selling field. Additionally, his work history includes extensive leadership
responsibility in the financial services and computer industries. Mr. Orr was
selected as Chief Executive Officer based on a track record leading complex
organizations, as well as strong executive and personal qualities. Mr. Orr
earned a BA in Psychology from Wesleyan University and an MBA from the
University of Connecticut. 


In 2005, Mr. Orr received the distinctive Circle of Honor Award from the Direct
Selling Education Foundation. In 2007, he was honored by the Direct Selling
Association with its prestigious Hall of Fame Award.


Mr. Orr will work out of the Corporation's offices in Vaudreuil, Quebec once all
immigration approvals have been obtained.


About Immunotec Inc.

Immunotec is a world class business opportunity supported by unique
scientifically proven products that improve wellness. Headquartered with
manufacturing facilities near Montreal, Canada, the Company also has
distribution capacities to support its commercial activities in Canada and
internationally to the United States, Europe, Mexico and the Caribbean.


The Company files its consolidated financial statements, its management and
discussion analysis report, its press releases and such other required documents
on the SEDAR database at www.sedar.com and on the Company's website at
www.immunotec.com. The common shares of the Company are listed on the TSX
Venture Exchange under the ticker symbol IMM. 


CAUTION REGARDING FORWARD-LOOKING STATEMENTS: Certain statements contained in
this news release are forward-looking and are subject to numerous risks and
uncertainties, known and unknown. For information identifying known risks and
uncertainties and other important factors that could cause actual results to
differ materially from those anticipated in the forward-looking statements,
please refer to the heading Risks and Uncertainties in Immunotec's most recent
Management's Discussion and Analysis, which can be found at www.sedar.com.
Consequently, actual results may differ materially from the anticipated results
expressed in these forward-looking statements.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Charles Orr
Immunotec Inc.
(450) 510-4463

International Metals Min... (TSXV:IMM)
Historical Stock Chart
From Nov 2024 to Dec 2024

International Metals Min... (TSXV:IMM)
Historical Stock Chart
From Dec 2023 to Dec 2024